US Rights Deal Will Make Proleukin Clinigen's Biggest Product

 
• By Sten Stovall
  
Handshake
Clinigen Agrees To Acquire US Rights To Novartis' cancer drug Proleukin • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business